Phanes Biotech

Phanes Biotech

Pre-clinical
San Diego, United StatesFounded 2018phanesbiotech.com

Every 3 seconds, one person worldwide develops dementia. Alzheimer’s disease (AD) contributes to 60–70% of cases of dementia. An estimated 5.9 million Americans live with the disease today, while the global total is about 44 million; these numbers are likely to reach 13.8 million in the U.S. and 131.5 million worldwide by 2050. AD is the sixth leading cause of death in the U.S., with a 146.2% increase as a cause of death between 2000 and 2018.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Funding information not available

About

Every 3 seconds, one person worldwide develops dementia. Alzheimer’s disease (AD) contributes to 60–70% of cases of dementia. An estimated 5.9 million Americans live with the disease today, while the global total is about 44 million; these numbers are likely to reach 13.8 million in the U.S. and 131.5 million worldwide by 2050. AD is the sixth leading cause of death in the U.S., with a 146.2% increase as a cause of death between 2000 and 2018.

AntibodiesBiologicsSmall Molecules